Suppression of matrix metalloproteinase-2-mediated cell invasion in U87MG, human glioma cells by anti-microtubule agent: in vitro study
1998

Estramustine Reduces Invasion of Glioblastoma Cells

publication Evidence: moderate

Author Information

Author(s): D Yoshida, JM Piepmeier, T Bergenheim, R Henriksson, A Teramoto

Primary Institution: Nippon Medical School

Hypothesis

Does estramustine affect matrix metalloproteinase-2 activity and cell invasion in glioma cells?

Conclusion

Estramustine phosphate inhibits the secretion of matrix metalloproteinases-2 and the invasiveness of human glioblastoma cells in vitro.

Supporting Evidence

  • An activated form of matrix metalloproteinase-2 diminished with increasing estramustine concentrations.
  • Collagenolysis assay showed 2.5- to 21-fold lower rates of enzymatic activity suppressed by estramustine.
  • Haptoinvasion assay revealed significant suppression of invasion in a dose-dependent manner with estramustine.

Takeaway

Estramustine is a drug that helps stop brain cancer cells from spreading by reducing a specific protein that helps them invade other tissues.

Methodology

The study used cell proliferation assays, zymograms, collagenolysis assays, and haptoinvasion assays to evaluate the effects of estramustine on glioma cells.

Limitations

The study did not examine the effects of estramustine on other matrix metalloproteinases beyond MMP-2.

Participant Demographics

Human glioblastoma cells (U87MG) were used in the study.

Statistical Information

P-Value

p<0.01

Statistical Significance

p<0.01

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication